Jeff Hall

Senior Editor, Diagnostic Imaging

Articles by Jeff Hall

In the newly released Lung-RADS 2022 classification system for computed tomography (CT) lung cancer screening, the American College of Radiology (ACR) has noted a variety of updates including new classification criteria for atypical pulmonary cysts and airway nodules, time intervals for nodule growth and a new stepped management approach for Lung-RADS categories 3 and 4A.

In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.

Reviewing data from over 4 million patients who presented to emergency departments with suspected urinary stone disease between 2012 and 2018, researchers noted a greater than 10 percent decrease in visits with no imaging study and a greater than 10 percent increase in visits with CT imaging.

For patients undergoing stereotactic body radiotherapy (SBRT) for prostate cancer, the acute genitourinary (GU) toxicity rate associated with the procedure was 19 percent lower with magnetic resonance imaging (MRI) guidance in comparison to computed tomography (CT) guidance, according to new research presented recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting.